Real-World Evidence Circles

06/02/2026

Trust isn’t a soft concept — it’s a system outcome.

What if trust isn’t built through messaging or intention, but emerges from the structure of how people, data, and decisions interact? The “Geometry of Trust” reframes trust as something measurable and designable — dependent on balance, coordination, and the integrity of underlying systems.

Discover how this perspective could transform healthcare — and why getting the structure right changes everything.

Read the full article:

How circular verification systems turn trust into infrastructure—embedding transparency, accountability, and shared proof into healthcare networks.

06/01/2026

𝐑𝐞𝐭𝐡𝐢𝐧𝐤𝐢𝐧𝐠 𝐭𝐡𝐞 𝐓𝐊𝐀 𝐑𝐞𝐜𝐨𝐯𝐞𝐫𝐲 𝐂𝐮𝐫𝐯𝐞: 𝐍𝐞𝐰 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐟𝐫𝐨𝐦 𝐌𝐎𝐓𝐈𝐕™

Are we settling for a plateau in post-operative pain recovery?

New preliminary data from the MOTIV™ study is challenging what we expect from long-term Total Knee Arthroplasty (TKA) outcomes. By tracking patients who utilized a non-opioid pain management agent as part of their surgical protocol, we are seeing a remarkable shift in the recovery curve.

𝐊𝐞𝐲 𝐓𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬 𝐟𝐫𝐨𝐦 𝐭𝐡𝐞 𝐝𝐚𝐭𝐚:

▪️𝐇𝐢𝐠𝐡𝐞𝐫 𝐒𝐭𝐚𝐫𝐭𝐢𝐧𝐠 𝐏𝐨𝐢𝐧𝐭, 𝐒𝐭𝐞𝐞𝐩𝐞𝐫 𝐃𝐫𝐨𝐩: The targeted cohort began with significantly higher pre-operative pain levels (5.6 VAS) compared to the broader patient baseline (4.3 VAS). Despite this, they experienced a sharp, significant reduction by the two-week mark.

▪️𝐒𝐮𝐬𝐭𝐚𝐢𝐧𝐞𝐝 𝐑𝐞𝐥𝐢𝐞𝐟: In the traditional TKA recovery cohort, pain reduction plateaus at 3 months (~2.0 VAS). However, the non-opioid cohort showed a continuous, sustained decline over the same period.

▪️𝐓𝐡𝐞 𝟗𝟎-𝐃𝐚𝐲 𝐃𝐢𝐟𝐟𝐞𝐫𝐞𝐧𝐜𝐞: At 3 months, the group achieved a remarkably low final pain score (~1.0), outperforming the general population and proving the value of integrated, non-opioid pain strategies.

These insights reinforce our commitment to non-opioid strategies that prioritize both safety and superior surgical outcomes.

Interested in the full MOTIV™ dataset? Let’s start the conversation.

05/28/2026

𝐖𝐇𝐀𝐓 𝐈𝐅 𝐏𝐎𝐒𝐓-𝐎𝐏 𝐏𝐀𝐈𝐍 𝐌𝐀𝐍𝐀𝐆𝐄𝐌𝐄𝐍𝐓 𝐃𝐈𝐃𝐍’𝐓 𝐇𝐀𝐕𝐄 𝐓𝐎 𝐑𝐄𝐋𝐘 𝐎𝐍 𝐎𝐏𝐈𝐎𝐈𝐃𝐒?

As our grows to 𝟏𝟓𝟕+ 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬, early signals from the data are starting to emerge — and they’re pointing toward something meaningful.

Orthopedic care still faces a critical reality: Most surgical patients are exposed to opioids. Even short-term use can lead to longer-term dependency risks.

But what happens when you introduce 𝐧𝐞𝐰, 𝐧𝐨𝐧-𝐨𝐩𝐢𝐨𝐢𝐝 𝐭𝐫𝐞𝐚𝐭𝐦𝐞𝐧𝐭𝐬 𝐢𝐧𝐭𝐨 𝐫𝐞𝐚𝐥-𝐰𝐨𝐫𝐥𝐝 𝐜𝐚𝐫𝐞?

We’re beginning to see 𝐝𝐢𝐫𝐞𝐜𝐭𝐢𝐨𝐧𝐚𝐥 𝐢𝐧𝐬𝐢𝐠𝐡𝐭𝐬 across the data — and they raise important questions about the future of pain management.

At our upcoming 𝐌𝐎𝐓𝐈𝐕™ 𝐂𝐢𝐫𝐜𝐥𝐞 𝐇𝐨𝐮𝐫 (𝐉𝐮𝐧𝐞 𝟏𝟕, 𝟕 𝐏𝐌 𝐄𝐒𝐓), we’ll take a closer look at:

✔️ Early trends from aggregated patient data
✔️ Signals tied to recovery pathways
✔️ What this could mean for orthopedic outcomes moving forward

This is just a preview of what’s coming.

Stay tuned — we’ll be sharing more leading up to the session.

05/26/2026

Most healthcare organizations say they take data governance seriously.
But if you ask a simple question — how do you know it’s actually working? — the answer is often unclear.

That’s the problem.

As data becomes central to care and research, governance isn’t just a compliance task anymore. It directly affects how safely data is used, how quickly research moves, and how much others trust your organization. Yet in many cases, it’s still not measured in a consistent, ongoing way.

This creates a blind spot.

Leaders rely heavily on data, but have limited visibility into how well the systems managing that data are performing. Without clear metrics, it’s difficult to judge risk, compare performance, or improve over time.
What would change if governance was measured as carefully as clinical outcomes or operational performance?

The article below looks at this shift and why it matters now:

How stewardship metrics make ethics measurable—turning governance, trust, consent, and accountability into auditable healthcare infrastructure.

05/25/2026

The line between “wellness tech” and “medical-grade” innovation is becoming sharper — and harder to cross.

Recent regulatory shifts are redefining what qualifies as clinical credibility, creating a clear divide between consumer-facing solutions and physician-trusted tools.

For healthcare providers and clinical researchers, this raises critical questions:

❓ What truly constitutes validated real-world evidence?
❓ How do we move from descriptive data to actionable clinical insight?
❓ And how can digital health solutions achieve both regulatory compliance and clinical trust?

Bridging this “medical-grade chasm” isn’t just a technical challenge — it’s a paradigm shift in how evidence is generated, validated, and applied in .

In this article, we explore how structured, auditable and clinician-led validation can unlock a new level of precision, reimbursement readiness, and :

FDA 2026 wellness guidance separates consumer health tools from medical-grade devices, requiring validated clinical accuracy for reimbursement and premium valuation.

05/21/2026

Healthcare data inconsistency isn’t loud — but its impact is massive.
Small variations in coding and definitions silently break analytics, slow innovation, and undermine AI reliability. At scale, these inconsistencies drive up costs, introduce compliance risks, and erode trust in outcomes.

Circle changes that. By standardizing how data is defined, captured, and connected, we create continuity you can rely on — powering accurate insights, faster research, and smarter systems.

Because in modern healthcare, consistency isn’t optional — it’s a competitive advantage.

Read more in the full article: https://hubs.ly/Q04hsPV10

Why inconsistent healthcare data creates hidden costs, unreliable AI, and compliance risk—and how structured continuity restores trust and scalability.

05/20/2026

We are pleased to bring our community together for the upcoming MOTIV™ Circle Hour, taking place virtually on 𝐉𝐮𝐧𝐞 𝟏𝟕𝐭𝐡 𝐚𝐭 𝟕:𝟎𝟎 𝐏𝐌 𝐄𝐒𝐓.

This session marks an important milestone for MOTIV™. 𝐖𝐢𝐭𝐡 𝟏𝟒𝟕 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐧𝐨𝐰 𝐢𝐧 𝐭𝐡𝐞 𝐂𝐢𝐫𝐜𝐥𝐞 𝐚𝐧𝐝 𝐠𝐫𝐨𝐰𝐢𝐧𝐠 𝐞𝐯𝐞𝐫𝐲 𝐝𝐚𝐲, we will be sharing a comprehensive review of the data aggregated to date, along with the insights shaping our next phase.

During this Circle Hour, we will:

✔️Present key findings and emerging trends across the data
✔️Highlight treatment insights derived from collective participation
✔️Outline strategic priorities and opportunities moving forward

MOTIV™ continues to be driven by the strength and engagement of its community. This session is an opportunity to align, learn, and build continued momentum together.

A formal invitation with full details and access information will follow shortly.

In the meantime, mark your calendar — we look forward to seeing you there and continuing to build momentum together.

05/19/2026

Are we measuring what truly matters in medicine?

Too often, clinical success is defined by improved numbers—not improved lives. Surrogate markers may be convenient, but they can mislead decisions, distort priorities, and delay meaningful impact for patients.

It’s time to refocus medicine on real outcomes: survival, function, and quality of life. Because progress isn’t about better data—it’s about better lives.

Read the full article to explore why outcomes must come first:

Why medicine must move beyond surrogate markers toward real patient outcomes—restoring meaning, ethics, and clinical relevance to evidence.

05/18/2026

Still measuring success by procedures? The future belongs to those who prove outcomes. See what’s changing:

CMS ACCESS ties MSK revenue to functional outcomes. Learn how PROMs, regenerative therapies, and sensor data validate recovery and prevent surgical spend.

05/15/2026

Most healthcare organizations can measure outcomes—but not the credibility behind them.

That blind spot is where risk quietly builds: decisions shaped by data that can’t always be fully verified, trusted, or traced. Over time, it doesn’t just impact research quality—it affects institutional confidence and long-term value.

We’ve become highly precise at counting activity, yet far less equipped to account for integrity.

What would change if truth itself were treated as an asset—and its absence as a liability?

This piece explores how rethinking data, trust, and accountability could reshape how healthcare measures value:

How ethical accounting turns integrity into an asset and deception into liability—bringing trust, verification, and accountability onto the balance sheet.